Previous Close | 33.37 |
Open | 33.47 |
Bid | 33.87 x 30000 |
Ask | 34.02 x 30000 |
Day's Range | 33.47 - 34.04 |
52 Week Range | 31.50 - 44.37 |
Volume | |
Avg. Volume | 591 |
Market Cap | 29.364B |
Beta (5Y Monthly) | 0.74 |
PE Ratio (TTM) | 7.40 |
EPS (TTM) | 4.60 |
Earnings Date | Mar 29, 2023 - Apr 03, 2023 |
Forward Dividend & Yield | 1.82 (5.47%) |
Ex-Dividend Date | Feb 15, 2023 |
1y Target Est | 52.09 |
Subscribe to Yahoo Finance Plus to view Fair Value for W8A.F
A group of 20 Republican state attorneys general on Wednesday told Walgreens Boots Alliance Inc and CVS Health Corp that they risk running afoul of federal and state law if they dispense the abortion drug mifepristone by mail. The move, announced by Missouri Attorney General Andrew Bailey, comes weeks after the U.S. Food and Drug Administration for the first time allowed retail pharmacies to dispense mifepristone, including by mail, provided they are certified under special safety rules for the drug. Walgreens and CVS have said they intend to become certified and dispense the drug in states where abortion is legal, though neither has yet done so.
One way for companies to bring more traffic to their stores is to provide services that customers can't get from an online retailer like Amazon (NASDAQ: AMZN), which could otherwise easily steal sales away from brick-and-mortar shops. Healthcare could provide such an opportunity, with CVS Health (NYSE: CVS) and Walgreens Boots Alliance (NASDAQ: WBA) making moves in recent years to make it easier for customers to take care of common health issues at their pharmacies rather than having to go to a primary care provider. Big-box retailer Walmart (NYSE: WMT) has gotten into the mix and has begun offering healthcare services at some of its stores.
These highly profitable, industry-leading businesses can deliver triple-digit total returns for retired investors.